Year |
Citation |
Score |
2019 |
Wu T, Kasper S, Wong RM, Bracken B. Identification of Differential Patterns of Oxidative Biomarkers in Prostate Cancer Progression. Clinical Genitourinary Cancer. PMID 31899150 DOI: 10.1016/J.Clgc.2019.09.014 |
0.473 |
|
2019 |
Majumdar S, Rinaldi JC, Malhotra NR, Xie L, Hu DP, Gauntner TD, Grewal HS, Hu WY, Kim SH, Katzenellenbogen JA, Kasper S, Prins GS. Differential Actions of Estrogen Receptor α and β via Non-Genomic Signaling in Human Prostate Stem and Progenitor Cells. Endocrinology. PMID 31433456 DOI: 10.1210/En.2019-00177 |
0.566 |
|
2019 |
Vummidi Giridhar P, Williams K, VonHandorf AP, Deford PL, Kasper S. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity. Cancer Research. PMID 30626627 DOI: 10.1158/0008-5472.Can-18-1753 |
0.621 |
|
2018 |
Wu T, Bracken B, Kasper S. Abstract LB-178: Oxidation markers in relation to prostate cancer and BPH and progression of prostate cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-178 |
0.572 |
|
2016 |
Fulford L, Milewski D, Ustiyan V, Ravishankar N, Cai Y, Le T, Masineni S, Kasper S, Aronow B, Kalinichenko VV, Kalin TV. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5. Science Signaling. 9: ra48. PMID 27165781 DOI: 10.1126/Scisignal.Aad5582 |
0.549 |
|
2016 |
Majumdar S, Rinaldi J, Gauntner T, Xie L, Hu W, Prins G, Malhotra N, Kasper S. ID: 22: DIFFERENTIAL ACTIONS OF ESTROGEN RECEPTOR α AND β VIA NON-GENOMIC SIGNALING IN HUMAN PROSTATE STEM-PROGENITOR CELLS Journal of Investigative Medicine. 64: 933-933. DOI: 10.1136/Jim-2016-000120.46 |
0.498 |
|
2016 |
Majumdar S, Malhotra N, Kasper S, Xie L, Gauntner T, Hu W, Prins G. PD35-09 DIFFERENTIAL ACTIONS OF ERα AND ERβ VIA NON-GENOMIC SIGNALING IN HUMAN PROSTATE STEM-PROGENITOR CELLS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1081 |
0.541 |
|
2014 |
Zhou J, Giridhar PV, Kasper S, Papautsky I. Modulation of rotation-induced lift force for cell filtration in a low aspect ratio microchannel. Biomicrofluidics. 8: 044112. PMID 25379097 DOI: 10.1063/1.4891599 |
0.447 |
|
2014 |
Kopras E, Potluri V, Bermudez ML, Williams K, Belcher S, Kasper S. Actions of endocrine-disrupting chemicals on stem/progenitor cells during development and disease. Endocrine-Related Cancer. 21: T1-12. PMID 24280134 DOI: 10.1530/Erc-13-0360 |
0.306 |
|
2013 |
Cai Y, Balli D, Ustiyan V, Fulford L, Hiller A, Misetic V, Zhang Y, Paluch AM, Waltz SE, Kasper S, Kalin TV. Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis. The Journal of Biological Chemistry. 288: 22527-41. PMID 23775078 DOI: 10.1074/Jbc.M113.455089 |
0.622 |
|
2013 |
Williams K, Motiani K, Giridhar PV, Kasper S. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches. Experimental Biology and Medicine (Maywood, N.J.). 238: 324-38. PMID 23598979 DOI: 10.1177/1535370213480714 |
0.318 |
|
2013 |
Zhou J, Giridhar PV, Kasper S, Papautsky I. Modulation of aspect ratio for complete separation in an inertial microfluidic channel. Lab On a Chip. 13: 1919-29. PMID 23529341 DOI: 10.1039/C3Lc50101A |
0.328 |
|
2013 |
Motiani K, Williams K, Girdhar PV, Mouraviev V, Bracken B, Kasper S. 254 Role Of Cd44 In Prostate Cancer Stem Cells The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1636 |
0.545 |
|
2012 |
Williams K, Ghosh R, Giridhar PV, Gu G, Case T, Belcher SM, Kasper S. Inhibition of stathmin1 accelerates the metastatic process. Cancer Research. 72: 5407-17. PMID 22915755 DOI: 10.1158/0008-5472.Can-12-1158 |
0.651 |
|
2011 |
Liu J, Pascal LE, Isharwal S, Metzger D, Ramos Garcia R, Pilch J, Kasper S, Williams K, Basse PH, Nelson JB, Chambon P, Wang Z. Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Molecular Endocrinology (Baltimore, Md.). 25: 1849-57. PMID 21940754 DOI: 10.1210/Me.2011-1081 |
0.641 |
|
2010 |
Zhang J, Gao N, DeGraff DJ, Yu X, Sun Q, Case TC, Kasper S, Matusik RJ. Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression. The Prostate. 70: 934-51. PMID 20209642 DOI: 10.1002/Pros.21128 |
0.55 |
|
2009 |
Kasper S. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens. Urologic Oncology. 27: 301-3. PMID 19414117 DOI: 10.1016/J.Urolonc.2008.12.012 |
0.55 |
|
2008 |
Kasper S. Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Reviews. 4: 193-201. PMID 18563640 DOI: 10.1007/S12015-008-9033-1 |
0.631 |
|
2008 |
Kasper S. Stem cells: The root of prostate cancer? Journal of Cellular Physiology. 216: 332-6. PMID 18459113 DOI: 10.1002/Jcp.21489 |
0.515 |
|
2008 |
Chaurand P, Rahman MA, Hunt T, Mobley JA, Gu G, Latham JC, Caprioli RM, Kasper S. Monitoring mouse prostate development by profiling and imaging mass spectrometry. Molecular & Cellular Proteomics : McP. 7: 411-23. PMID 17991918 DOI: 10.1074/Mcp.M700190-Mcp200 |
0.619 |
|
2007 |
Kasper S. Characterizing the prostate stem cell. The Journal of Urology. 178: 375. PMID 17561165 DOI: 10.1016/J.Juro.2007.05.031 |
0.564 |
|
2007 |
Gu G, Yuan J, Wills M, Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Research. 67: 4807-15. PMID 17510410 DOI: 10.1158/0008-5472.Can-06-4608 |
0.545 |
|
2007 |
Tillman JE, Yuan J, Gu G, Fazli L, Ghosh R, Flynt AS, Gleave M, Rennie PS, Kasper S. DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Research. 67: 4630-7. PMID 17510388 DOI: 10.1158/0008-5472.Can-06-4556 |
0.706 |
|
2007 |
Ghosh R, Gu G, Tillman E, Yuan J, Wang Y, Fazli L, Rennie PS, Kasper S. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. The Prostate. 67: 1038-52. PMID 17455228 DOI: 10.1002/Pros.20601 |
0.756 |
|
2007 |
Gipp J, Gu G, Crylen C, Kasper S, Bushman W. Hedgehog pathway activity in the LADY prostate tumor model. Molecular Cancer. 6: 19. PMID 17343742 DOI: 10.1186/1476-4598-6-19 |
0.54 |
|
2006 |
Wang Y, Kasper S, Yuan J, Jin RJ, Zhang J, Ishii K, Wills ML, Hayward SW, Matusik RJ. Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 1074-88. PMID 16894353 DOI: 10.1038/Labinvest.3700463 |
0.596 |
|
2006 |
Pitkänen-Arsiola T, Tillman JE, Gu G, Yuan J, Roberts RL, Wantroba M, Coetzee GA, Cookson MS, Kasper S. Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability. The Prostate. 66: 1177-93. PMID 16652386 DOI: 10.1002/Pros.20450 |
0.727 |
|
2006 |
Kasper S, Cookson MS. Mechanisms leading to the development of hormone-resistant prostate cancer. The Urologic Clinics of North America. 33: 201-10, vii. PMID 16631458 DOI: 10.1016/J.Ucl.2005.12.010 |
0.595 |
|
2006 |
Shao TC, Li HL, Kasper S, Matusik R, Ittmann M, Cunningham GR. Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice. The Prostate. 66: 369-76. PMID 16302273 DOI: 10.1002/Pros.20354 |
0.563 |
|
2005 |
Kasper S. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis. Journal of Cellular Biochemistry. 94: 279-97. PMID 15565647 DOI: 10.1002/Jcb.20339 |
0.596 |
|
2004 |
Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Cancer Research. 64: 5489-95. PMID 15289359 DOI: 10.1158/0008-5472.Can-03-3117 |
0.591 |
|
2004 |
Kasper S, Smith JA. Genetically modified mice and their use in developing therapeutic strategies for prostate cancer. The Journal of Urology. 172: 12-9. PMID 15201729 DOI: 10.1097/01.Ju.0000132122.93436.Aa |
0.572 |
|
2004 |
Masumori N, Tsuchiya K, Tu WH, Lee C, Kasper S, Tsukamoto T, Shappell SB, Matusik RJ. An allograft model of androgen independent prostatic neuroendocrine carcinoma derived from a large probasin promoter-T antigen transgenic mouse line. The Journal of Urology. 171: 439-42. PMID 14665950 DOI: 10.1097/01.Ju.0000099826.63103.94 |
0.598 |
|
2004 |
Zhang J, Gao N, Kasper S, Reid K, Nelson C, Matusik RJ. An androgen-dependent upstream enhancer is essential for high levels of probasin gene expression. Endocrinology. 145: 134-48. PMID 14500578 DOI: 10.1210/En.2003-0568 |
0.503 |
|
2004 |
Bhowmick NA, Kasper S. 603: Prostate Androgen Responsiveness Involve Stromal Transforming Growth Factor-Beta Signaling The Journal of Urology. 171: 160-160. DOI: 10.1016/S0022-5347(18)37865-0 |
0.482 |
|
2003 |
Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y, Kasper S, Case T, Roberts RL, Shappell SB, Moses HL, Matusik RJ. The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia (New York, N.Y.). 5: 267-77. PMID 12869309 DOI: 10.1016/S1476-5586(03)80058-1 |
0.504 |
|
2003 |
Kasper S, Tu W, Roberts RL, Shappell SB. Transgenic mouse models for prostate cancer. Identification of an androgen-dependent promoter and creation and characterization of the long probasin promoter-Large T antigen (LPB-Tag) model. Methods in Molecular Medicine. 81: 113-47. PMID 12725118 DOI: 10.1385/1-59259-372-0:113 |
0.555 |
|
2002 |
Zhang Y, Yu J, Unni E, Shao TC, Nan B, Snabboon T, Kasper S, Andriani F, Denner L, Marcelli M. Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB. Human Gene Therapy. 13: 2051-64. PMID 12490000 DOI: 10.1089/10430340260395901 |
0.541 |
|
2001 |
Chaurand P, DaGue BB, Ma S, Kasper S, Caprioli RM. Strain-based sequence variations and structure analysis of murine prostate specific spermine binding protein using mass spectrometry. Biochemistry. 40: 9725-33. PMID 11583173 DOI: 10.1021/Bi010424L |
0.397 |
|
2001 |
Andriani F, Nan B, Yu J, Li X, Weigel NL, McPhaul MJ, Kasper S, Kagawa S, Fang B, Matusik RJ, Denner L, Marcelli M. Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells. Journal of the National Cancer Institute. 93: 1314-24. PMID 11535706 DOI: 10.1093/Jnci/93.17.1314 |
0.573 |
|
2001 |
Lareyre JJ, Winfrey VP, Kasper S, Ong DE, Matusik RJ, Olson GE, Orgebin-Crist MC. Gene duplication gives rise to a new 17-kilodalton lipocalin that shows epididymal region-specific expression and testicular factor(s) regulation. Endocrinology. 142: 1296-308. PMID 11181548 DOI: 10.1210/Endo.142.3.8045 |
0.309 |
|
2001 |
Lareyre JJ, Reid K, Nelson C, Kasper S, Rennie PS, Orgebin-Crist MC, Matusik RJ. Characterization of an androgen-specific response region within the 5' flanking region of the murine epididymal retinoic acid binding protein gene. Biology of Reproduction. 63: 1881-92. PMID 11090461 DOI: 10.1095/Biolreprod63.6.1881 |
0.457 |
|
2000 |
Zhang J, Thomas TZ, Kasper S, Matusik RJ. A Small Composite Probasin Promoter Confers High Levels of Prostate-Specific Gene Expression through Regulation by Androgens and Glucocorticoids in Vitro and in Vivo* *This work was supported by R01-DK-55748 from the NIH and the Frances Williams Preston Laboratories of the T. J. Martell Foundation. Transgenic mice were bred by the Transgenic Core/ES Cell Shared Resource of the Vanderbilt-Ingram Cancer Center (NCI Grant 2P30-CA-68485-05). Endocrinology. 141: 4698-4710. PMID 28204369 DOI: 10.1210/Endo.141.12.7837 |
0.63 |
|
2000 |
Kasper S, Matusik RJ. Rat probasin: structure and function of an outlier lipocalin. Biochimica Et Biophysica Acta. 1482: 249-58. PMID 11058766 DOI: 10.1016/S0167-4838(00)00170-9 |
0.462 |
|
1999 |
Shappell SB, Boeglin WE, Olson SJ, Kasper S, Brash AR. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. The American Journal of Pathology. 155: 235-45. PMID 10393855 DOI: 10.1016/S0002-9440(10)65117-6 |
0.607 |
|
1999 |
Kasper S, Rennie PS, Bruchovsky N, Lin L, Cheng H, Snoek R, Dahlman-Wright K, Gustafsson JA, Shiu RP, Sheppard PC, Matusik RJ. Selective activation of the probasin androgen-responsive region by steroid hormones. Journal of Molecular Endocrinology. 22: 313-25. PMID 10343290 DOI: 10.1677/Jme.0.0220313 |
0.457 |
|
1999 |
Lareyre JJ, Thomas TZ, Zheng WL, Kasper S, Ong DE, Orgebin-Crist MC, Matusik RJ. A 5-kilobase pair promoter fragment of the murine epididymal retinoic acid-binding protein gene drives the tissue-specific, cell-specific, and androgen-regulated expression of a foreign gene in the epididymis of transgenic mice. The Journal of Biological Chemistry. 274: 8282-90. PMID 10075734 DOI: 10.1074/Jbc.274.12.8282 |
0.356 |
|
1998 |
Snoek R, Bruchovsky N, Kasper S, Matusik RJ, Gleave M, Sato N, Mawji NR, Rennie PS. Differential transactivation by the androgen receptor in prostate cancer cells. The Prostate. 36: 256-63. PMID 9719026 DOI: 10.1002/(Sici)1097-0045(19980901)36:4<256::Aid-Pros7>3.0.Co;2-D |
0.65 |
|
1998 |
Lareyre JJ, Zheng WL, Zhao GQ, Kasper S, Newcomer ME, Matusik RJ, Ong DE, Orgebin-Crist MC. Molecular cloning and hormonal regulation of a murine epididymal retinoic acid-binding protein messenger ribonucleic acid. Endocrinology. 139: 2971-81. PMID 9607808 DOI: 10.1210/Endo.139.6.6074 |
0.315 |
|
1998 |
Bai GE, Kasper S, Matusik RJ, Rennie PS, Moshier JA, Krongrad A. Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells Journal of Andrology. 19: 127-135. PMID 9570735 DOI: 10.1002/J.1939-4640.1998.Tb01981.X |
0.636 |
|
1997 |
Yan Y, Sheppard PC, Kasper S, Lin L, Hoare S, Kapoor A, Dodd JG, Duckworth ML, Matusik RJ. Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. The Prostate. 32: 129-39. PMID 9215401 DOI: 10.1002/(Sici)1097-0045(19970701)32:2<129::Aid-Pros8>3.0.Co;2-H |
0.54 |
|
1997 |
Snoek R, Rennie PS, Kasper S, Matusik RJ, Bruchovsky N. Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides. The Journal of Steroid Biochemistry and Molecular Biology. 59: 243-50. PMID 9010316 DOI: 10.1016/S0960-0760(96)00116-1 |
0.504 |
|
Show low-probability matches. |